Brief: AnaptysBio Q1 Net Income USD -39.329 Million
05/05/2025 21:15
May 05 (Reuters) - AnaptysBio Q1 income from operations USD -27.539 million. Q1 operating expenses USD 55.31 million Q1 collaboration revenue USD 27.771 million
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties